Director Jonathan Bedway granted 750 CBFV shares in equity award

Rhea-AI Filing Summary

Bedway Jonathan reported acquisition or exercise transactions in this Form 4 filing.

CB Financial Services, Inc. director Jonathan Bedway received a grant of 750 shares of common stock on February 16, 2026, recorded at a per-share price of $0.00, indicating a stock award rather than an open-market purchase. Following this award, his directly held common stock, including restricted shares, totals 20,749 shares. Several awards are structured as restricted stock that vest 20% per year beginning on February 16 of 2023, 2024, 2025, and 2026, with an additional grant scheduled to vest 100% on February 16, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bedway Jonathan

(Last) (First) (Middle)

100 N. MARKET STREET

(Street)

CARMICHAELS PA 15320

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CB Financial Services, Inc. [ CBFV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/16/2026		A		750(5)	A	$0	20,749(1)(2)(3)(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes shares of restricted stock which vest at a rate of 20% per year commencing on February 16, 2023.

2. Includes shares of restricted stock which vest at a rate of 20% per year commencing on February 16, 2024.

3. Includes shares of restricted stock which vest at a rate of 20% per year commencing on February 16, 2025.

4. Includes shares of restricted stock which vest at a rate of 20% per year commencing on February 16, 2026.

5. Shares of restricted stock vest 100% on February 16, 2027.

	/s/ Matthew Lawrence, pursuant to power of attorney	02/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Jonathan Bedway report in this Form 4 for CBFV?

Jonathan Bedway reported receiving a grant of 750 shares of CB Financial Services common stock. The award was priced at $0.00 per share, indicating a stock grant rather than a market purchase, and increased his directly held total to 20,749 shares including restricted stock.

Was the Bedway CBFV Form 4 transaction a stock purchase or a grant?

The Form 4 shows a stock grant, not a market purchase. Code “A” and a $0.00 per-share price indicate a grant, award, or similar acquisition of 750 common shares, consistent with equity compensation instead of an open-market buy on an exchange.

How many CBFV shares does Jonathan Bedway hold after this Form 4?

After the reported award, Bedway directly holds 20,749 shares of CB Financial Services common stock. This total includes both unrestricted and restricted shares, with several restricted stock grants subject to multi-year vesting schedules through February 16, 2027.

What are the vesting terms of Bedway’s CBFV restricted stock?

Bedway’s restricted stock awards vest over several years. Some grants vest at 20% per year starting on February 16 of 2023, 2024, 2025, and 2026, while another grant is scheduled to vest 100% on February 16, 2027, according to the footnotes.

Does this CBFV Form 4 indicate indirect ownership or related entities?

The filing describes Bedway’s ownership as direct, with no nature-of-ownership description referencing separate entities. The footnotes focus on vesting schedules for restricted stock rather than indicating trusts, LLCs, or disclaimers of voting or investment authority.

What does transaction code “A” mean in the CBFV Form 4?

Transaction code “A” on this Form 4 is described as a grant, award, or other acquisition. Here, it reflects the issuance of 750 shares of CB Financial Services common stock to director Jonathan Bedway as equity compensation rather than an ordinary market trade.